Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Mar 2017 09:39:00 AM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1270.30 [ -0.24% ]TCS 2454.90 [ -0.22% ]

Sensex29453.15
120.99 0.41%

Nifty9116.85
30.55 0.34%

Midcap13902.70
49.30 0.36%

Smallcap14120.78
92.84 0.66%



Sun Pharmaceuticals Industries Ltd :

 704.20  0.35 [0.05%]

ISIN: INE044A01036  | NSE: SUNPHARMA |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 524715  |  Add To Watchlist

Price Information
• Open 702.90
• High 705.25
• Low 702.00
• Previous Close 703.85
• Shares Traded 1216600
• 52 Wk High Price 854.50
• 52 Wk High Date 05-08-2016
• 52 Wk Low Price 572.40
• 52 Wk Low Date 09-11-2016
• Face Value 1.00


Fundamentals
• Market Capital (Rs.cr) 167782.00
• EPS (Rs.)(TTM) -
• P/E Ratio(TTM) -
• Book Value (Rs.) 89.50
• Price to Book Value 7.81
• Equity (Rs.cr.) 239.93
• Traded Value (Rs.lac) 2350.91


Corporate Actions
Ex-Date Purpose (Rs.)
2010-11-25 Stock Split from Rs.5 to Rs.1 (0)
2011-09-02 350% Dividend (3.5)
2012-08-14 425% Interim Dividend (4.25)
2013-07-29 1:1 Bonus Issue of Equity Shares (0)
2013-09-19 250% Dividend (2.5)
2014-09-11 150% Dividend (1.5)
2015-10-21 300% Dividend (3)
2016-09-08 100% Dividend (1)


Index Names
BSE-200
CNX Nifty
BSE-100
BSE-500
BSE HC
BSE Sensex


Related Companies
Stock Name Price
BAJAJTEMPO 4619.00




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 1868.34 7628.37 7614.46
• Net Profit (Rs.cr) -162.66 -396.69 -1336.33
• Net Profit Var (%) -14.00 68.00 14.00
• EPS (Rs) - - -
• P/E Ratio - - -
• Operating Profit Margin - -3.71 -
• CPS (Rs.) - - -
• P/C Ratio - - -
• Div% - - 100.00

Announcements
12-08-2015 Board of Sun Pharmaceuticals Industries recommends final dividend
24-06-2016 Board of Sun Pharmaceutical Industries approves buyback of shares for aggregate Rs 675 cr
23-12-2011 Caraco Pharmaceuticals received tentative approval for Precedex injection
13-04-2015 Outcome of Allotment Committee meeting of Sun Pharmaceutical Industries
04-05-2016 Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
05-06-2013 Sun Pharma announces United States Food and Drug Administration approval for generic Depo -Testost
06-06-2016 Sun Pharma announces divestment of two US manufacturing units
18-11-2010 Sun Pharma announces USFDA approval for generic Diltiazem ER
28-03-2012 Sun Pharma announces USFDA approval for generic Seroquel tablets
10-12-2011 Sun Pharma announces USFDA approval for generic Ultram ER Tablets
19-07-2011 Sun Pharma announces USFDA approval for generic Uroxatral ER tablets
14-02-2014 Sun Pharma appoints additional director
28-10-2015 Sun Pharma completes tender offer for InSite Vision
01-12-2014 Sun Pharma gets FIPB approval to issue shares to non-residents
21-02-2011 Sun Pharma gets UK MHRA nod for Suveniz tablets product
15-11-2016 Sun Pharma provides update on its CSR initiative
25-11-2010 Sun Pharma receives USFDA approval For generic Cymbalta
18-05-2012 Sun Pharma receives USFDA approval for generic Plavix tablets
16-07-2014 Sun Pharmaceutical announces acquisition of Pharmalucence
12-04-2011 Sun Pharmaceutical Industries & Merck & Co announces joint venture
14-02-2017 Sun Pharmaceutical Industries allots 20,993 equity shares
23-07-2015 Sun Pharmaceutical Industries allots equity shares
03-11-2015 Sun Pharmaceutical Industries completes acquisition of InSite Vision Incorporated
16-12-2016 Sun Pharmaceutical Industries completes acquisition of Ocular Technologies
22-10-2016 Sun Pharmaceutical Industries completes divestment of its seven presciption brands
22-12-2016 Sun Pharmaceutical Industries plans to acquire branded oncology product - Odomzo
24-12-2015 Sun Pharmaceutical Industries provides update on subsidiary
30-05-2012 Sun Pharmaceutical Industries recommends dividend
20-07-2011 Sun Pharmaceutical Industries to announce Q1 results
22-10-2012 Sun Pharmaceutical Industries to announce Q2 results
31-01-2012 Sun Pharmaceutical Industries to announce Q3 results
16-10-2012 Sun Pharmaceutical Industries to hold AGM
06-08-2012 Sun Pharmaceutical Industries to hold board meeting
01-03-2017 Sun Pharmaceutical Industries to present data on Tildrakizumab Clinical Development Program
04-10-2012 Sun Pharmaceutical Industries to raise funds
28-07-2016 Sun Pharmaceuticals and Almirall enter into licensing agreement
21-01-2012 Sun Pharmaceuticals gets final approval for generic Lopressor HCT tablets
29-04-2015 Sun Pharmaceuticals Industries allots equity shares
14-12-2015 Sun Pharmaceuticals Industries announces divestment of US manufacturing unit
11-09-2014 Sun Pharmaceuticals Industries to hold AGM
29-10-2014 Sun Pharmaceuticals Industries to hold board meeting
31-07-2014 Sun Pharmaceuticals Industries to hold EGM
17-01-2012 Sun Pharmaceuticals received tentative approval for generic Lunesta
21-04-2012 Sun Pharmaceuticals received tentative approval for the Ibandronate Sodium injection
19-04-2011 Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
22-03-2017 101510 243532 41.68 71209265 170032.00
21-03-2017 114298 338937 33.72 79928592 235091.00
20-03-2017 41166 118448 34.75 29114654 83838.10
17-03-2017 78604 228542 34.39 55549447 161453.00
16-03-2017 92981 374199 24.85 66100193 267138.00


Bulk Deals
Deal Date Client Name Type Qty Price
11-04-2016 GENESIS EMERGING MARKETS L P B 15858723 816.69
11-04-2016 GENESIS INDIAN INVESTMENT COMPANY LIMITED S 15858723 816.69
14-03-2016 GENESIS EMERGING MARKETS L P B 15850000 864.01
14-03-2016 GENESIS INDIAN INVESTMENT COMPANY LIMITED S 15850000 864.01


Block Deals
Deal Date Client Name Type Qty Price
23-02-2016 NEW INDIA INVESTMENT TRUST PLC B 320500 886.80
23-02-2016 NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED S 320500 886.80
01-02-2013 LIBERTY MUTUAL RETIREMENT PLAN MASTER TRUST B 258513 720.00
01-02-2013 MICM-LIBRTY LIFE ASUR CO BOSTON NEWPORT TIGER S 258513 720.00
17-10-2011 ISHARES MSCI INDIA MAURITIUS COMPANY B 120311 477.50


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  quest financial services  •  aurobindo pharma  •  natura  •  kpit technologies  •  axisban
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech